Creative Planning

Position in ABCL — AbCellera Biologics Inc.

CIK 1540235 OVERLAND PARK, KS

Position in ABCL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$336,199

+$182,462 QoQ

Shares Held

42,828

-2.8% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#75

of 150 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. ABCL ranks #141 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$336,199	42,828	-2.8%	Shares	Sole	2026-08-13
2026-03-31	$153,737	44,051	+5.3%	Shares	Sole	2026-05-12
2025-12-31	$143,106	41,844	-12.3%	Shares	Sole	2026-02-17
2025-09-30	$240,096	47,733	+16.4%	Shares	Sole	2025-11-14
2025-06-30	$140,640	41,003	+6.9%	Shares	Sole	2025-08-08
2025-03-31	$85,513	38,347	-46.3%	Shares	Sole	2025-05-15
2024-12-31	$209,277	71,426	+99.5%	Shares	Defined	2025-02-14
2024-09-30	$93,077	35,799	+208.9%	Shares	Sole	2024-10-11
2024-03-31	$52,497	11,589	-15.5%	Shares	Defined	2024-05-13
2023-12-31	$78,340	13,720	+17.2%	Shares	Defined	2024-02-14
2023-06-30	$75,601	11,703	—	Shares	Sole	2023-07-21
No filing history on record for this holder in this stock.